Public Act 103-0602
 
HB4621 EnrolledLRB103 36415 RLC 66517 b

    AN ACT concerning criminal law.
 
    Be it enacted by the People of the State of Illinois, 
represented in the General Assembly:
 
    Section 5. The Substance Use Disorder Act is amended by 
changing Section 5-23 as follows:
 
    (20 ILCS 301/5-23)
    Sec. 5-23. Drug Overdose Prevention Program.
    (a) Reports.
        (1) The Department may publish annually a report on 
    drug overdose trends statewide that reviews State death 
    rates from available data to ascertain changes in the 
    causes or rates of fatal and nonfatal drug overdose. The 
    report shall also provide information on interventions 
    that would be effective in reducing the rate of fatal or 
    nonfatal drug overdose and on the current substance use 
    disorder treatment capacity within the State. The report 
    shall include an analysis of drug overdose information 
    reported to the Department of Public Health pursuant to 
    subsection (e) of Section 3-3013 of the Counties Code, 
    Section 6.14g of the Hospital Licensing Act, and 
    subsection (j) of Section 22-30 of the School Code.
        (2) The report may include:
            (A) Trends in drug overdose death rates.
            (B) Trends in emergency room utilization related 
        to drug overdose and the cost impact of emergency room 
        utilization.
            (C) Trends in utilization of pre-hospital and 
        emergency services and the cost impact of emergency 
        services utilization.
            (D) Suggested improvements in data collection.
            (E) A description of other interventions effective 
        in reducing the rate of fatal or nonfatal drug 
        overdose.
            (F) A description of efforts undertaken to educate 
        the public about unused medication and about how to 
        properly dispose of unused medication, including the 
        number of registered collection receptacles in this 
        State, mail-back programs, and drug take-back events. 
            (G) An inventory of the State's substance use 
        disorder treatment capacity, including, but not 
        limited to:
                (i) The number and type of licensed treatment 
            programs in each geographic area of the State.
                (ii) The availability of medication-assisted 
            treatment at each licensed program and which types 
            of medication-assisted treatment are available.
                (iii) The number of recovery homes that accept 
            individuals using medication-assisted treatment in 
            their recovery.
                (iv) The number of medical professionals 
            currently authorized to prescribe buprenorphine 
            and the number of individuals who fill 
            prescriptions for that medication at retail 
            pharmacies as prescribed.
                (v) Any partnerships between programs licensed 
            by the Department and other providers of 
            medication-assisted treatment.
                (vi) Any challenges in providing 
            medication-assisted treatment reported by programs 
            licensed by the Department and any potential 
            solutions. 
    (b) Programs; drug overdose prevention.
        (1) The Department may establish a program to provide 
    for the production and publication, in electronic and 
    other formats, of drug overdose prevention, recognition, 
    and response literature. The Department may develop and 
    disseminate curricula for use by professionals, 
    organizations, individuals, or committees interested in 
    the prevention of fatal and nonfatal drug overdose, 
    including, but not limited to, drug users, jail and prison 
    personnel, jail and prison inmates, drug treatment 
    professionals, emergency medical personnel, hospital 
    staff, families and associates of drug users, peace 
    officers, firefighters, public safety officers, needle 
    exchange program staff, and other persons. In addition to 
    information regarding drug overdose prevention, 
    recognition, and response, literature produced by the 
    Department shall stress that drug use remains illegal and 
    highly dangerous and that complete abstinence from illegal 
    drug use is the healthiest choice. The literature shall 
    provide information and resources for substance use 
    disorder treatment.
        The Department may establish or authorize programs for 
    prescribing, dispensing, or distributing opioid 
    antagonists for the treatment of drug overdose. Such 
    programs may include the prescribing of opioid antagonists 
    for the treatment of drug overdose to a person who is not 
    at risk of opioid overdose but who, in the judgment of the 
    health care professional, may be in a position to assist 
    another individual during an opioid-related drug overdose 
    and who has received basic instruction on how to 
    administer an opioid antagonist.
        (2) The Department may provide advice to State and 
    local officials on the growing drug overdose crisis, 
    including the prevalence of drug overdose incidents, 
    programs promoting the disposal of unused prescription 
    drugs, trends in drug overdose incidents, and solutions to 
    the drug overdose crisis.
        (3) The Department may support drug overdose 
    prevention, recognition, and response projects by 
    facilitating the acquisition of opioid antagonist 
    medication approved for opioid overdose reversal, 
    facilitating the acquisition of opioid antagonist 
    medication approved for opioid overdose reversal, 
    providing trainings in overdose prevention best practices, 
    connecting programs to medical resources, establishing a 
    statewide standing order for the acquisition of needed 
    medication, establishing learning collaboratives between 
    localities and programs, and assisting programs in 
    navigating any regulatory requirements for establishing or 
    expanding such programs. 
        (4) In supporting best practices in drug overdose 
    prevention programming, the Department may promote the 
    following programmatic elements:
            (A) Training individuals who currently use drugs 
        in the administration of opioid antagonists approved 
        for the reversal of an opioid overdose.
            (B) Directly distributing opioid antagonists 
        approved for the reversal of an opioid overdose rather 
        than providing prescriptions to be filled at a 
        pharmacy.
            (C) Conducting street and community outreach to 
        work directly with individuals who are using drugs.
            (D) Employing community health workers or peer 
        recovery specialists who are familiar with the 
        communities served and can provide culturally 
        competent services.
            (E) Collaborating with other community-based 
        organizations, substance use disorder treatment 
        centers, or other health care providers engaged in 
        treating individuals who are using drugs.
            (F) Providing linkages for individuals to obtain 
        evidence-based substance use disorder treatment.
            (G) Engaging individuals exiting jails or prisons 
        who are at a high risk of overdose.
            (H) Providing education and training to 
        community-based organizations who work directly with 
        individuals who are using drugs and those individuals' 
        families and communities.
            (I) Providing education and training on drug 
        overdose prevention and response to emergency 
        personnel and law enforcement.
            (J) Informing communities of the important role 
        emergency personnel play in responding to accidental 
        overdose.
            (K) Producing and distributing targeted mass media 
        materials on drug overdose prevention and response, 
        the potential dangers of leaving unused prescription 
        drugs in the home, and the proper methods for 
        disposing of unused prescription drugs. 
    (c) Grants.
        (1) The Department may award grants, in accordance 
    with this subsection, to create or support local drug 
    overdose prevention, recognition, and response projects. 
    Local health departments, correctional institutions, 
    hospitals, universities, community-based organizations, 
    and faith-based organizations may apply to the Department 
    for a grant under this subsection at the time and in the 
    manner the Department prescribes. Eligible grant 
    activities include, but are not limited to, purchasing and 
    distributing opioid antagonists, hiring peer recovery 
    specialists or other community members to conduct 
    community outreach, and hosting public health fairs or 
    events to distribute opioid antagonists, promote harm 
    reduction activities, and provide linkages to community 
    partners.
        (2) In awarding grants, the Department shall consider 
    the overall rate of opioid overdose, the rate of increase 
    in opioid overdose, and racial disparities in opioid 
    overdose experienced by the communities to be served by 
    grantees. The Department shall encourage all grant 
    applicants to develop interventions that will be effective 
    and viable in their local areas.
        (3) (Blank).
        (3.5) Any hospital licensed under the Hospital 
    Licensing Act or organized under the University of 
    Illinois Hospital Act shall be deemed to have met the 
    standards and requirements set forth in this Section to 
    enroll in the drug overdose prevention program upon 
    completion of the enrollment process except that proof of 
    a standing order and attestation of programmatic 
    requirements shall be waived for enrollment purposes. 
    Reporting mandated by enrollment shall be necessary to 
    carry out or attain eligibility for associated resources 
    under this Section for drug overdose prevention projects 
    operated on the licensed premises of the hospital and 
    operated by the hospital or its designated agent. The 
    Department shall streamline hospital enrollment for drug 
    overdose prevention programs by accepting such deemed 
    status under this Section in order to reduce barriers to 
    hospital participation in drug overdose prevention, 
    recognition, or response projects. 
        (4) In addition to moneys appropriated by the General 
    Assembly, the Department may seek grants from private 
    foundations, the federal government, and other sources to 
    fund the grants under this Section and to fund an 
    evaluation of the programs supported by the grants.
    (d) Health care professional prescription of opioid 
antagonists. 
        (1) A health care professional who, acting in good 
    faith, directly or by standing order, prescribes or 
    dispenses an opioid antagonist to: (a) a patient who, in 
    the judgment of the health care professional, is capable 
    of administering the drug in an emergency, or (b) a person 
    who is not at risk of opioid overdose but who, in the 
    judgment of the health care professional, may be in a 
    position to assist another individual during an 
    opioid-related drug overdose and who has received basic 
    instruction on how to administer an opioid antagonist 
    shall not, as a result of his or her acts or omissions, be 
    subject to: (i) any disciplinary or other adverse action 
    under the Medical Practice Act of 1987, the Physician 
    Assistant Practice Act of 1987, the Nurse Practice Act, 
    the Pharmacy Practice Act, or any other professional 
    licensing statute or (ii) any criminal liability, except 
    for willful and wanton misconduct.
        (1.5) Notwithstanding any provision of or requirement 
    otherwise imposed by the Pharmacy Practice Act, the 
    Medical Practice Act of 1987, or any other law or rule, 
    including, but not limited to, any requirement related to 
    labeling, storage, or recordkeeping, a health care 
    professional or other person acting under the direction of 
    a health care professional may, directly or by standing 
    order, obtain, store, and dispense an opioid antagonist to 
    a patient in a facility that includes, but is not limited 
    to, a hospital, a hospital affiliate, or a federally 
    qualified health center if the patient information 
    specified in paragraph (4) of this subsection is provided 
    to the patient. A person acting in accordance with this 
    paragraph shall not, as a result of his or her acts or 
    omissions, be subject to: (i) any disciplinary or other 
    adverse action under the Medical Practice Act of 1987, the 
    Physician Assistant Practice Act of 1987, the Nurse 
    Practice Act, the Pharmacy Practice Act, or any other 
    professional licensing statute; or (ii) any criminal 
    liability, except for willful and wanton misconduct. 
        (2) A person who is not otherwise licensed to 
    administer an opioid antagonist may in an emergency 
    administer without fee an opioid antagonist if the person 
    has received the patient information specified in 
    paragraph (4) of this subsection and believes in good 
    faith that another person is experiencing a drug overdose. 
    The person shall not, as a result of his or her acts or 
    omissions, be (i) liable for any violation of the Medical 
    Practice Act of 1987, the Physician Assistant Practice Act 
    of 1987, the Nurse Practice Act, the Pharmacy Practice 
    Act, or any other professional licensing statute, or (ii) 
    subject to any criminal prosecution or civil liability, 
    except for willful and wanton misconduct.
        (3) A health care professional prescribing an opioid 
    antagonist to a patient shall ensure that the patient 
    receives the patient information specified in paragraph 
    (4) of this subsection. Patient information may be 
    provided by the health care professional or a 
    community-based organization, substance use disorder 
    program, or other organization with which the health care 
    professional establishes a written agreement that includes 
    a description of how the organization will provide patient 
    information, how employees or volunteers providing 
    information will be trained, and standards for documenting 
    the provision of patient information to patients. 
    Provision of patient information shall be documented in 
    the patient's medical record or through similar means as 
    determined by agreement between the health care 
    professional and the organization. The Department, in 
    consultation with statewide organizations representing 
    physicians, pharmacists, advanced practice registered 
    nurses, physician assistants, substance use disorder 
    programs, and other interested groups, shall develop and 
    disseminate to health care professionals, community-based 
    organizations, substance use disorder programs, and other 
    organizations training materials in video, electronic, or 
    other formats to facilitate the provision of such patient 
    information. 
        (4) For the purposes of this subsection:
        "Opioid antagonist" means a drug that binds to opioid 
    receptors and blocks or inhibits the effect of opioids 
    acting on those receptors, including, but not limited to, 
    naloxone hydrochloride or any other similarly acting drug 
    approved by the U.S. Food and Drug Administration.
        "Health care professional" means a physician licensed 
    to practice medicine in all its branches, a licensed 
    physician assistant with prescriptive authority, a 
    licensed advanced practice registered nurse with 
    prescriptive authority, an advanced practice registered 
    nurse or physician assistant who practices in a hospital, 
    hospital affiliate, or ambulatory surgical treatment 
    center and possesses appropriate clinical privileges in 
    accordance with the Nurse Practice Act, or a pharmacist 
    licensed to practice pharmacy under the Pharmacy Practice 
    Act. 
        "Patient" includes a person who is not at risk of 
    opioid overdose but who, in the judgment of the physician, 
    advanced practice registered nurse, or physician 
    assistant, may be in a position to assist another 
    individual during an overdose and who has received patient 
    information as required in paragraph (2) of this 
    subsection on the indications for and administration of an 
    opioid antagonist.
        "Patient information" includes information provided to 
    the patient on drug overdose prevention and recognition; 
    how to perform rescue breathing and resuscitation; opioid 
    antagonist dosage and administration; the importance of 
    calling 911; care for the overdose victim after 
    administration of the overdose antagonist; and other 
    issues as necessary. 
    (e) Drug overdose response policy. 
        (1) Every State and local government agency that 
    employs a law enforcement officer or fireman as those 
    terms are defined in the Line of Duty Compensation Act 
    must possess opioid antagonists and must establish a 
    policy to control the acquisition, storage, 
    transportation, and administration of such opioid 
    antagonists and to provide training in the administration 
    of opioid antagonists. A State or local government agency 
    that employs a probation officer, as defined in Section 9b 
    of the Probation and Probation Officers Act, or a fireman 
    as defined in the Line of Duty Compensation Act but does 
    not respond to emergency medical calls or provide medical 
    services shall be exempt from this subsection.
        (2) Every publicly or privately owned ambulance, 
    special emergency medical services vehicle, non-transport 
    vehicle, or ambulance assist vehicle, as described in the 
    Emergency Medical Services (EMS) Systems Act, that 
    responds to requests for emergency services or transports 
    patients between hospitals in emergency situations must 
    possess opioid antagonists. 
        (3) Entities that are required under paragraphs (1) 
    and (2) to possess opioid antagonists may also apply to 
    the Department for a grant to fund the acquisition of 
    opioid antagonists and training programs on the 
    administration of opioid antagonists. 
(Source: P.A. 101-356, eff. 8-9-19; 102-598, eff. 1-1-22.)
 
    Section 10. The Pretrial Services Act is amended by 
changing Sections 1, 1.5, 2, 3, 4, 5, 8, 9, 10, 12, 13, 14, 15, 
17, 22, 24, 30, and 33 and by adding Sections 0.02, 0.03, and 
0.04 as follows:
 
    (725 ILCS 185/0.02 new)
    Sec. 0.02. Definitions. In this Act: 
    "Director" means the Director of the Office of Statewide 
Pretrial Services.
    "Local pretrial services" means a pretrial services other 
than the Office who is providing pretrial services.
    "Pretrial services" means any providing services to the 
circuit court as provided for in this Act, including the 
Office.
    "Office" means the Office of Statewide Pretrial Services.
 
    (725 ILCS 185/0.03 new)
    Sec. 0.03. Office of Statewide Pretrial Services; 
establishment. There is established in the judicial branch of 
State government an office to be known as the Office of 
Statewide Pretrial Services. This office shall be under the 
supervision and direction of a Director who shall be appointed 
by a vote of a majority of the Illinois Supreme Court Justices 
for a 4-year term and until a successor is appointed and 
qualified. The Director shall adopt rules, instructions, and 
orders, consistent with this Act, further defining the 
organization of this office and the duties of its employees. 
The Illinois Supreme Court shall approve or modify an 
operational budget submitted to it by the Office of Statewide 
Pretrial Services and set the number of employees each year.
 
    (725 ILCS 185/0.04 new)
    Sec. 0.04. Powers and duties.
    (a) The Office shall provide pretrial services as provided 
in Section 7 to circuit courts or counties without existing 
pretrial services agencies.
    (b) The Office shall develop, establish, adopt, and 
enforce uniform standards for pretrial services in this State.
    (c) The Office may:
        (1) hire and train State employed pretrial personnel;
        (2) establish qualifications for pretrial officers as 
    to hiring, promotion, and training;
        (3) establish a system of training and orientation for 
    local pretrial services agencies;
        (4) Develop standards and approve employee 
    compensation schedules for local pretrial services 
    agencies;
        (5) establish a system of uniform forms;
        (6) develop standards for a system of recordkeeping 
    for local pretrial services agencies;
        (7) gather statistics and develop research for 
    planning of pretrial services in Illinois;
        (8) establish a means of verifying the conditions for 
    reimbursement under this Act for local pretrial services 
    agencies and develop criteria for approved costs for 
    reimbursement;
        (9) monitor and evaluate all pretrial programs 
    operated by local pretrial services agencies;
        (10) review and approve annual plans submitted by 
    local pretrial services agencies; and
        (11) establish such other standards and regulations 
    and do all acts necessary to carry out the intent and 
    purposes of this Act. 
 
    (725 ILCS 185/1)  (from Ch. 38, par. 301)
    Sec. 1. Pretrial services shall be provided by a local 
pretrial services agency or the Office. The pretrial services 
agency shall provide Each circuit court shall establish a 
pretrial services agency to provide the circuit court with 
accurate background data regarding the pretrial release of 
persons charged with felonies and effective supervision of 
compliance with the terms and conditions imposed on release.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/1.5)
    Sec. 1.5. Framework facilitating the hiring and training 
of new State-employed pretrial services personnel to serve 
circuit courts or counties without existing pretrial services 
agencies.  Notwithstanding anything in this Act to the 
contrary, the Office shall hire Supreme Court is encouraged to 
establish a framework that facilitates the hiring and train 
training of new State-employed pretrial services personnel to 
serve circuit courts or counties without existing pretrial 
services agencies, as required by Section 1. Nothing in this 
amendatory Act of the 103rd General Assembly shall be 
constructed to invalidate, diminish, or otherwise interfere 
with any collective bargaining agreement or representation 
rights under the Illinois Public Labor Relations Act, if 
applicable. 
(Source: P.A. 102-694, eff. 1-7-22.)
 
    (725 ILCS 185/2)  (from Ch. 38, par. 302)
    Sec. 2. Local pretrial Pretrial services agencies may be 
independent divisions of the circuit courts accountable to the 
chief judge or his designee for program activities. The 
agencies shall be supervised by a program director appointed 
by the chief judge and removable for cause. The chief judge or 
his designee shall have the authority to hire, terminate or 
discipline local pretrial services agency personnel on 
recommendation of the program director.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/3)  (from Ch. 38, par. 303)
    Sec. 3. Pretrial services shall be provided by the Office 
The functions of the pretrial services agency shall be 
assigned to the Department of Probation and Court Services or 
other arm of the court where the volume of criminal 
proceedings does not justify the establishment of a local 
pretrial services agency separate division.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/4)  (from Ch. 38, par. 304)
    Sec. 4. All local pretrial services agency personnel shall 
be full-time employees supervised by the director and, except 
for secretarial staff, subject to the hiring and training 
requirements established by the Office Supreme Court as 
provided in "An Act providing for a system of probation, for 
the appointment and compensation of probation officers, and 
authorizing the suspension of final judgment and the 
imposition of sentence upon persons found guilty of certain 
defined crimes and offenses, and legalizing their ultimate 
discharge without punishment", approved June 10, 1911, as 
amended.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/5)  (from Ch. 38, par. 305)
    Sec. 5. The compensation for local pretrial services 
agency personnel shall be commensurate with salaries and other 
benefits accorded probation department employees.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/8)  (from Ch. 38, par. 308)
    Sec. 8. In addition to the foregoing, local pretrial 
services agencies may with the approval of the chief judge 
provide one or more of the following services to the circuit 
court:
    (a) Supervise compliance with the terms and conditions 
imposed by the courts for appeal bonds; and
    (b) Assist in such other pretrial services activities as 
may be delegated to the agency by the court.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/9)  (from Ch. 38, par. 309)
    Sec. 9. Pretrial services agencies shall have standing 
court authority to interview and process all persons charged 
with non-capital felonies either before or after first 
appearance if the person is in custody. The chief judge and 
program director of the pretrial services agency may establish 
interviewing priorities where resources do not permit total 
coverage, but no other criteria shall be employed to exclude 
categories of offenses or offenders from program operations.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/10)  (from Ch. 38, par. 310)
    Sec. 10. The chief judge and program director of the local 
pretrial services agency shall continuously assess the 
benefits of agency intervention before or after the first 
appearance of accused persons. In determining the best 
allocation of available resources, consideration shall be 
given to current release practices of first appearance judges 
in misdemeanor and lesser felony cases; the logistics of 
pre-first appearance intervention where decentralized 
detention facilities are utilized; the availability of 
verification resources for pre-first appearance intervention; 
and the ultimate goal of prompt and informed determinations of 
pretrial release conditions.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/12)  (from Ch. 38, par. 312)
    Sec. 12. Interviews shall be individually conducted by 
agency personnel in facilities or locations which assure an 
adequate opportunity for discussion, consistent with security 
needs.
    The chief judge or his designee shall maintain a 
continuous liaison between the pretrial services agency 
director and the sheriff, or other affected law enforcement 
agencies, to assure that pretrial services interviewers have 
prompt access consistent with security and law enforcement 
needs to all prisoners after booking.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/13)  (from Ch. 38, par. 313)
    Sec. 13. Information received from the arrested person as 
a result of the agency interview shall be recorded on uniform 
interview forms created by the Office.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/14)  (from Ch. 38, par. 314)
    Sec. 14. The pretrial services agency shall, after 
interviewing arrestees, immediately verify and supplement the 
information required by the uniform interview form before 
submitting its report to the court. Minimum verification shall 
include the interviewee's prior criminal record, residency, 
and employment circumstances. The chief judge or his designee 
shall assist the pretrial services agency program director in 
establishing and maintaining cooperation with the circuit 
clerk and law enforcement information systems to assure the 
prompt verification of prior criminal records.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/15)  (from Ch. 38, par. 315)
    Sec. 15. Verified and supplemental information assembled 
by the pretrial services agency shall be recorded on a uniform 
reporting form established by the Office Supreme Court.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/17)  (from Ch. 38, par. 317)
    Sec. 17. Reports shall be in writing, signed by an 
authorized representative of the pretrial services agency, and 
prepared on the uniform reporting form. Copies of the report 
shall be provided to all parties and counsel of record. If the 
report is filed with the court, the court shall deny public 
access to the report. 
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/22)  (from Ch. 38, par. 322)
    Sec. 22. If so ordered by the court, the pretrial services 
agency shall prepare and submit for the court's approval and 
signature a uniform release order on the uniform form 
established by the Office Supreme Court in all cases where an 
interviewee may be released from custody under conditions 
contained in an agency report. Such conditions shall become 
part of the conditions of pretrial release. A copy of the 
uniform release order shall be provided to the defendant and 
defendant's attorney of record, and the prosecutor.
(Source: P.A. 101-652, eff. 1-1-23.)
 
    (725 ILCS 185/24)  (from Ch. 38, par. 324)
    Sec. 24. Where functions of the local pretrial services 
agency have been delegated to a probation department or other 
arm of the court under Section 3, their records shall be 
segregated from other records. Two years after the date of the 
first interview with a pretrial services agency 
representative, the defendant may apply to the chief circuit 
judge, or a judge designated by the chief circuit judge for 
these purposes, for an order expunging from the records of the 
pretrial services agency all files pertaining to the 
defendant.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/30)  (from Ch. 38, par. 330)
    Sec. 30. Records and statistics shall be maintained by 
local pretrial services agencies of their operations and 
effect upon the criminal justice system, with monthly reports 
submitted to the circuit court and the Office Supreme Court on 
a uniform statistical form developed by the Supreme Court.
(Source: P.A. 84-1449.)
 
    (725 ILCS 185/33)  (from Ch. 38, par. 333)
    Sec. 33. The Office Supreme Court shall pay from funds 
appropriated to it for this purpose 100% of all approved costs 
for pretrial services, including pretrial services officers, 
necessary support personnel, travel costs reasonably related 
to the delivery of pretrial services, space costs, equipment, 
telecommunications, postage, commodities, printing and 
contractual services. Costs shall be reimbursed monthly, based 
on an annual a plan and budget approved by the Office Supreme 
Court. No department may be reimbursed for costs which exceed 
or are not provided for in the approved annual plan and budget. 
The Mandatory Arbitration Fund may be used to reimburse 
approved costs for pretrial services.
(Source: P.A. 94-91, eff. 7-1-05; 94-839, eff. 6-6-06; 95-331, 
eff. 8-21-07; 95-707, eff. 1-11-08.)
 
    (725 ILCS 185/6 rep.)
    Section 15. The Pretrial Services Act is amended by 
repealing Section 6.
 
    Section 99. Effective date. This Act takes effect upon 
becoming law, except that Sections 10 and 15 take effect on 
July 1, 2025.